How leading pharma organizations are putting AI agents to work

Everyone is talking about AI in clinical research. Few are showing what it actually looks like in practice.

Join Medable for an interactive session on how agentic AI is moving beyond pilots to transform clinical operations. The team will explore why most AI initiatives stall, what separates experimentation from enterprise adoption, and how leading sponsors and CROs are building the operating model needed to scale AI successfully across programs.

You'll also learn how a structured digital protocol creates a trusted foundation for connected workflows, reducing manual effort while enabling AI agents to deliver measurable value throughout the clinical trial lifecycle.

The session includes a live demo of the agents that can support your clinical teams today, backed by real deployment examples and measurable results across digital data flow (DDF), clinical monitoring, and TMF management. Leave with an actionable roadmap you can apply to your own AI strategy.

Key Learnings:

Why clinical operations are the critical bottleneck and how agentic AI, grounded in regulatory frameworks like 21 CFR Part 11 and ICH E6 R3, can expand operational capacity, reduce systemic inefficiency, and reshape the productivity curve of clinical development.
Why the next evolution of clinical trial execution isn't just generating documents faster; it's creating a connected digital foundation that keeps people, processes, and AI working from the same trusted source of truth.
Why implementing agentic AI isn't just a technology change but an operating model shift, redefining how clinical teams work, measure success, and collaborate with AI agents.
How purpose-built clinical agents work in practice, where you’ll meet agents already primed for orchestration, such as Medable’s DDF, CRA, TMF, PI Summary Agents, and more. See how they assist with risk detection, QTL monitoring, eCOA oversight, and compliance while acting as expert collaborators, not just tools.

Alison Holland

Chief Customer Officer

Medable

Alison (Ali) Holland is Chief Customer Officer at Medable, where she partners with customers to maximize the value of digital platform technologies and modern clinical research methodologies, helping to optimize the ROI and—most importantly—the outcomes for sponsors, sites, and patients. Ali has over 20 years of experience in various leadership roles, including Six Sigma Black Belt at Covance and, subsequently, with LabCorp as Business Head and Global General Manager of Customer & Therapeutic Business Units. Having been engaged in over 300 studies across Biotechs, Pharma, and all geographies, Ali brings unparalleled clinical insight and technical excellence regarding the operational needs of sites and patients.

Jessica Dolfi

SVP, Solution Consulting

Medable

Jessica Dolfi is a people, presales, and product leader with over 18 years of experience in the clinical trial technology space. She blends a consultative and customer-requirement-gathering approach with product management to deliver leading solutions that meet the industry’s business objectives. She works with internal and external customers to understand business needs, prioritize and plan deliverables, and position and market solutions.

Nick Fuentes

Forward Deployed Engineer - Agentic AI for Clinical Development

Medable

Nick Fuentes is a Forward Deployed Engineer at Medable, where he works alongside life sciences organizations to design and deploy AI agents that transform clinical trial operations and accelerate clinical development. During his tenure at Medable, he has held several leadership roles, including Program Director for enterprise accounts, overseeing the global delivery of clinical trial technology solutions. Before joining Medable, Nick supported vaccine manufacturing and fill-finish delivery, helping advance critical vaccines from production to patients. Nick brings an interdisciplinary background in engineering and data science and is also a TEDx speaker.

Jaime Green

Science Writer

Freelance Journalist

Jaime Green is a freelance science writer and author. Her work has appeared in The New York Times Magazine, The Atlantic, Aeon, Popular Science, Slate, Astrobites, and elsewhere. She is the series editor of The Best American Science and Nature Writing and author of The Possibility of Life: Science, Imagination, and Our Quest for Kinship in the Cosmos.

Country

How leading pharma organizations are putting AI agents to work

Key Learnings:

Panelists

Moderator

Register for the webinar